Skip to main content
. 2026 Jun 24;18(13):2052. doi: 10.3390/cancers18132052
ET Essential thrombocythemia
PMF Primary myelofibrosis
PV Polycythemia vera
MPN Myeloproliferative neoplasm
NK Natural killer
HLA Human leukocyte antigen
SNP Single-nucleotide polymorphism
iPSC Induced pluripotent stem cell
MK Megakaryocyte
scRNA-seq Single-cell RNA sequencing
MDS Molecular dynamics simulation